Q1 2026 argenx SE Earnings Call Transcript
(Operator instructions) After the speaker and it's been placed on mute to prevent any background noise.
After the speaker's remarks, Uthere will be a question-and-answer session. Thank you. I'd like to introduce Beth DelGiacco, Vice President of Corporate Affairs. You may now begin your call.
Thank you. A press release was issued earlier today with our first-quarter 2026 financial results and business update. This can be found on our website along with the presentation for today's webcast.
Before we begin on slide 2, I'd like to remind you that forward-looking statements may be presented during this call. These may include statements about our future expectations, clinical development, regulatory timelines, the potential success of our product candidates, financial projections, and upcoming milestones. Actual results may differ materially from those indicated by these statements.
Argenix is not under any obligation to update statements
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
